GBT: Pfizer's dealmaking continues as GBT, Biohaven acquisitions close
The pharma giant has closed $17 billion in M&A activity this week.
Read full article »
GBT is a California-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of sickle cell diseases.
Read more